Heart Failure Flashcards
Sacubitril
Class: ARNi
+ Valsartan
Preferred over ACEi
MOA:
- Angiotensin receptor-neprilysin inhibitor
- Blocks neprilysin
- ARB for angiotensin II accumulation
Use(s):
- Patients w/HFrEF
- LVEF < 40%
Adverse Effect(s):
- Hypotension
- Hyperkalemia
- Angioedema
- Teratogenic (Valsartan)
- Dec. renal function w/NSAID
Contraindication(s):
- Angioedema
- Patients taking ACEi
- Patients w/diabetes, Aliskiren
Captopril
Enalapril
Lisinopril
MOA:
- Dec. afterload
- Dec. preload
- Dec. long-term heart remodeling
Use(s):
- Patients w/heart failure
- Patients w/dec. LVEF
- Patients w/past MI
Adverse Effect(s):
- Hypotension
- Persistent dry cough
- Hyperkalemia
- Angioedema
- Acute renal failure
- Teratogenic
Contraindication(s):
- Patients w/bilateral renal artery stenosis
- Patients w/angioedema
- Pregnancy
Candesartan
Valsartan
Class: ARB
MOA:
- Potent competitive antagonist
- Angiotensin type I receptor
- NO effect on bradykinin level
Use(s):
- Heart failure
Adverse Effect(s):
- Hypotension
- Hyperkalemia
- Angioedema
- Acute renal failure
- Teratogenic
Bisoprolol
Carvediolol
Metoprolol
Class: B-blocker
Recommended in addition to ACEi
MOA:
- Dec. HR & contractility
- Inhibit renin release
- Dec. remodelig & hypertrophy
- Initial exacerbation of symptoms
Use(s):
- Symptomatic heart failure
- Asymptomatic patients w/dec. LVEF
- Asymptomatic patients w/past MI
- Decompensated HF (cautiously)
Adverse Effect(s): - Fluid retention
Contraindication(s):
- Cardiogenic shock
- Asthmatics
- Severe bradycardia
Diuretics
MOA:
- Dec. plasma volume
- Dec. preload
- Dec. CO & O2 demand
- Dec. afterload
Use(s):
- Pulmonary congestion
- Peripheral edema
- Dec. volume overload
- CHF
Spironolactone
Class: Thiazide
MOA:
- Aldosterone antagonist
- Prevent Na retention
- Prevent myocardial hypertrophy
- Prevent hypokalemia
Use(s):
- Advanced heart failure
Adverse Effect(s):
- Hyperkalemia
- GI disturbances
- CNS effects
- Endocrine abnormalities
Hydralazine + Isosorbide dinitrate
MOA:
- Inc. vasodilation = dec. preload
- Inc. arterial dilation
- Dec. systemic arterial resistance
- Dec. afterload
Use(s):
- LVEF
- Patients not able to use ACEi or ARB
- AA patients w/advanced HF
Adverse Effect(s):
- Headache
- Dizziness
- Tachycardia
- Peripheral neuritis
- Lupus-like syndrome
Contraindication(s):
- Sildenafil
Dapagliflozin
Class: SGLT2 Inhibitor
MOA:
- Osmotic diuresis & natriuresis
- Dec. arterial pressure & stiffness
- Dec. preload/afterload
- Favorable effects on myocardial remodeling
Use(s):
- Dec. HF hospitalizations
- Patients w/diabetes
Adverse Effect(s): - UTI
Ivabradine
Class: If Channel Inhibitor
MOA:
- Inhibit cardiac pacemaker If current
- Dec. HR
Adverse Effect(s):
- Bradycardia
- Atrial fibrillation
- Sinus arrest
- QT prolongation
- Torsade de pointes
Contraindication(s):
- HFpEF/decompensated HF
- Arrythmia
- Heart block
- BP < 90/50 mmHg
- HR < 90/min
- Severe liver failure
- CYP3A4 inhibitors